Pall and Artesyn Biosolutions team to industrialize single-use tech

By Melissa Fassbender

- Last updated on GMT

(Image: Getty/scyther5)
(Image: Getty/scyther5)
Pall Corporation and Artesyn Biosolutions will co-develop clinical to commercial-scale solutions for single-use automated bioprocessing systems.

The strategic collaboration is between Pall’s biotech business unit and Artesyn Biosolutions, a manufacturer of single-use components and fluid management technologies.

"Our long-standing relationship with Artesyn that has now been formalized as a collaboration to combine and leverage our technologies to deliver industrial and modular single-use bioprocess solutions,"​ said Helene Pora, VP technical communication and regulatory strategy at Pall.

Together, Pora said the companies will be able to deliver automated single-use solutions to accelerate the speed of implementation and time to market for customers.

"And ultimately, this collaboration takes another step forward in industrializing the single-use industry,"​ she told us.

The partnership also advances Pall Biotech's expansion of its Allegro single-use solution portfolio from upstream through downstream and to final filling, according to the company.

Related news

Show more

Related products

show more

Connectivity & Integration in Biomanufacturing

Connectivity & Integration in Biomanufacturing

Wheeler Bio | 17-Nov-2022 | Technical / White Paper

As the Pharma 4.0 initiative sets a new industry paradigm, more biomanufacturing companies are asking how they can design and build facilities that apply...

GMP manufacturing of buffers and liquid blends

GMP manufacturing of buffers and liquid blends

Actylis – The Partner of Choice | 16-Nov-2022 | Technical / White Paper

Actylis manufactures buffers, process solutions, cleaning solutions, Water for Injection (WFI) for further processing, and custom liquid blends in compliance...

Custom manufacturing of protease inhibitor PMSF

Custom manufacturing of protease inhibitor PMSF

Actylis – The Partner of Choice | 09-Nov-2022 | Technical / White Paper

By combining 75+ years of manufacturing and sourcing expertise, Actylis provides a wide portfolio of GMP ingredients to the pharma & biopharma market,...

Scalability, Quality, and Speed with Transposons

Scalability, Quality, and Speed with Transposons

Wheeler Bio | 20-Oct-2022 | Technical / White Paper

To solve for the significant bottlenecks often presented by conventional cell line development processes, this article discusses how Wheeler Bio is leveraging...

Related suppliers

Follow us


View more